Deprescribing antihypertensives in primary care: clinical and safety outcomes among older adults

There was no difference in BP control at 12 months after deprescribing despite a transient decline at 3 months. This supports the feasibility of deprescribing antihypertensives in older adults in primary care. Further research is needed to evaluate the safety outcomes in larger populations with specific cardiovascular comorbidities.